Description:
Velasof is a fixed-dose combination of Sofosbuvir, a hepatitis C virus (HCV) nucleotide anaVelasof is a potent antiviral therapy designed to treat chronic Hepatitis C virus (HCV) infection. It combines velpatasvir and sofosbuvir, which act by blocking essential viral enzymes to halt replication.
Suitable for all major HCV genotypes, Velasof offers high cure rates with a simplified once-daily dosage. It is especially valued for its safety, minimal side effects, and convenience in achieving sustained virologic response (SVR). alog NS5B polymerase inhibitor, and Velpatasvir, an HCV NS5A inhibitor.
Share your experience with our medical product. Write a review!
25 Apr 2026
World Liver Day 2026: Signs, Causes & How to Protect Your Liver Naturally
The liver is one of the most vital organs in the human body, responsible for detoxification, metabolism, and nutrient storage. Yet, liver health is often overlooked until symptoms become serious.
15 Apr 2026
World Health Day 2026: Small Health Habits That Prevent Big Diseases
Every year, World Health Day reminds us of something very simple yet powerful-our health deserves attention every single day, not only when something goes wrong. World Health Day 2026 is a good moment
25 Mar 2026
Transdermal Patches 2026: Latest Trends, Benefits & How They’re Revolutionizing Pain & Nicotine Relief
Transdermal patches are advanced drug delivery systems that deliver medication through the skin directly into the bloodstream. In 2026, new health technology trends are making transdermal patches more
14 Mar 2026
How Carica Papaya Leaf Extract Supports Platelet Recovery: Evidence, Uses & Best Practices
A healthy platelet count is essential for proper clotting, immune defense, and overall blood health. When platelet levels fall below normal-commonly referred to as low platelet count-the body becomes
